Page 38 - RxExam's Naplex Theory Review Part-1
P. 38

www.pharmacyexam.com                                                                   Krisman


                Drug Interactions with ACE Inhibitors and Angiotensin II Receptor Antagonists:

                Thiazide and loop             Sudden and severe hypotension is reported within the first 1 to 3 hours
                diuretics                     after the initial dose of Ace-Inhibitors or Angiotensin II antagonists in
                                              sodium and water depleted patients.

                Potassium sparing             Hyperkalemia is reported. Serum potassium concentration should be
                diuretics                     monitored regularly.

                Estrogen                      May cause sodium and water retention. May reduce the antihypertensive
                                              effects of ACE inhibitors and Angiotensin II receptor antagonists.

                Tetracycline                  May form chelation with Quinapril due to its high magnesium content.
                                              Concurrent use may reduce the absorption of Tetracycline by 40%.

                NSAIDs and COX-2              In patients who are elderly, volume-depleted or with compromised
                Inhibitors                    renal function, co-administration of NSAIDs, including selective COX-2
                                              inhibitors, with ACE inhibitors or Angiotensin II receptor antagonists
                                              may result in deterioration of renal function, including possible acute
                                              renal failure.


               Aldosterone Antagonists and Renin Inhibitor:

                               Dose             Special Notes

               Spironolactone  25-200 mg per    1). Spironolactone (Aldactone) is a specific pharmacologic antagonist of
               (Tablet)        day given in     aldosterone, acting primarily through competitive binding of receptors
                               either single or   at the aldosterone-dependent sodium-potassium exchange site in the
                               divided doses.   distal convoluted renal tubule.

                                                2). It is indicated for the treatment of:
                                                I. Primary hyperaldosteronism
                                                II. Edematous conditions associated with:
                                                (a) Congestive heart failure
                                                (b) Cirrhosis of the liver accompanied by edema and/or ascites
                                                (c) Nephrotic syndrome
                                                III. Hypertension, hypokalemia and severe heart failure

                                                3). The following test is employed as an initial diagnostic measure to
                                                provide presumptive evidence of primary hyperaldosteronism while
                                                patients are on normal diets.

                                                Long Test: Spironolactone (Aldactone) is administered at a daily dosage
                                                of 400 mg for three to four weeks. Correction of hypokalemia and
                                                hypertension provides presumptive evidence for the diagnosis of
                                                primary hyperaldosteronism.


                                                             37
   33   34   35   36   37   38   39   40   41   42   43